Hamartomatous polyposis syndromes

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 4, Issue 9, 2007, Pages 492-502

  Zbuk, Kevin M ^a   Eng, Charis ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 1; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE LKB1; RAPAMYCIN; SMAD4 PROTEIN; TEMSIROLIMUS; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AUTOSOMAL DOMINANT INHERITANCE; BREAST CANCER; CANCER RISK; CLINICAL FEATURE; COLON CANCER; COLORECTAL CANCER; COWDEN SYNDROME; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SURVEILLANCE; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; ENDOSCOPY; EVIDENCE BASED MEDICINE; GASTROINTESTINAL POLYPOSIS; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; GRAFT REJECTION; HAMARTOMATOUS POLYPOSIS SYNDROME; HUMAN; JUVENILE POLYP; MALIGNANT TRANSFORMATION; MONOTHERAPY; NONHUMAN; PATHOGENESIS; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; REVIEW; SERTOLI CELL TUMOR; SOMATIC MUTATION; SYSTEMATIC REVIEW; THYROID FOLLICULAR CARCINOMA; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR GENE; UTERINE CERVIX TUMOR;

GASTROINTESTINAL NEOPLASMS; GERM-LINE MUTATION; HAMARTOMA; HAMARTOMA SYNDROME, MULTIPLE; HUMANS; INTESTINAL POLYPOSIS; PEUTZ-JEGHERS SYNDROME; POPULATION SURVEILLANCE; PTEN PHOSPHOHYDROLASE; RISK FACTORS;

EID: 34548501301     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0902     Document Type: Review

References (79)

1. Nagy R et al. (2004) Highly penetrant hereditary cancer syndromes. Oncogene 23: 6445-6470
2. Wang ZJ et al. (1999) Allelic imbalance at the LKB1 (STK11) locus in tumours from patients with Peutz-Jeghers' syndrome provides evidence for a hamartoma-(adenoma)-carcinoma sequence. J Pathol 188: 9-13
3. Kutscher AH et al. (1960) Incidence of Peutz-Jeghers syndrome. Am J Dig Dis 5: 576-577
4. Utsunomiya J et al. (1975) Peutz-Jeghers syndrome: Its natural course and management. Johns Hopkins Med J 136: 71-82
5. McGarrity T J and Amos C (2006) Peutz-Jeghers syndrome: Clinicopathology and molecular alterations. Cell Mol Life Sci 63: 2135-2144
6. Giardiello FM and Trimbath JD (2006) Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hapatol 4: 408-415
7. Giardiello FM et al. (1987) Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 316: 1511-1514
8. Estrada R and Spjut HJ (1983) Hamartomatous polyps in Peutz-Jeghers syndrome. A light-, histochemical, and electron-microscopic study. Am J Surg Pathol 7: 747-754
9. Giardiello FM et al. (2000) Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119: 1447-1453
10. Lim W et al. (2004) Relative frequency and morphology of cancers in STK11 mutation carriers. Gastroenterology 126: 1788-1794
11. Srivatsa PJ et al. (1994) Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz-Jeghers syndrome. Gynecol Oncol 53: 256-264
12. Scully RE et al. (1970) Sex cord tumor with annular tubules a distinctive ovarian tumor of the Peutz-Jeghers syndrome. Cancer 25: 1107-1121
13. Terauchi S et al. (2006) Double-balloon endoscopy and Peutz-Jeghers syndrome: A new look at an old disease. Proc (Bayl Univ Med Cent) 19: 335-337
14. Volikos E et al. (2006) LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome. J Med Genet 43: E18
15. Sweet K et al. (2005) Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA 294 2465-2473
16. Alessi DR et al. (2006) LKB1-dependent signaling pathways. Annu Rev Biochem 75: 137-163
17. Corradetti MN et al. (2004) Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. Genes Dev 18: 1533-1538
18. Amos CI et al. (2004) Genotype-phenotype correlations in Peutz-Jeghers syndrome. J Med Genet 41: 327-333
19. Miyoshi H et al. (2002) Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res 62: 2261-2266
20. Zbuk KM and Eng C (2007) Cancer phenomics: RET and PTEN as illustrative models. Nat Rev Cancer 7: 35-45
21. Nelen MR et al. (1997) Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 6: 1383-1387
22. The NCCN Genetic/Familial High-Risk Assessment: Breast and Ovarian Guideline (V.1.2007) ©2006 National Comprehensive Cancer Network, Inc. To view the most recent and complete version of the guideline, go online to www.nccrr.org (accessed July 1 2007)
23. Gorlin RJ et al. (1992) Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 44: 307-314
24. Wiedemann HR et al. (1983) The proteus syndrome. Partial gigantism of the hands and/or feet, nevi, hemihypertrophy, subcutaneous tumors, macrocephaly or other skull anomalies and possible accelerated growth and visceral affections. Eur J Pediatr, 140: 5-12
25. Starink TM et al. (1986) The Cowden syndrome: A clinical and genetic study in 21 patients. Clin Genet 29: 222-233
26. Weber HC et al. (1998) Germline PTEN/MMAC1/TEP1 mutations and association with gastrointestinal manifestations in Cowden disease. Gastroenterology 114: 2902
27. Marra G et al. (1994) Cowden's disease with extensive gastrointestinal polyposis. J Clin Gastroenterol 18: 42-47
28. MoGarrity TJ et al. (2003) GI polyposis and glycogenic acanthosis of the esophagus associated with PTEN mutation positive Cowden syndrome in the absence of cutaneous manifestations. Am J Gastroenterol 98: 1429-1434
29. Eng C (2000) Will the real Cowden syndrome please stand up: Revised diagnostic criteria. J Med Genet 37: 828-830
30. Marsh DJ et al. (1998) Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 7: 507-515
31. Bosserhoff AK et al. (2006) Multiple colon carcinomas in a patient with Cowden syndrome. Int J Mol Med 18: 643-647
32. Carethers JM et al. (1998) Absence of PTEN/MMAC1 germ-line mutations in sporadic Bannayan-Riley-Ruvalcaba syndrome. Cancer Res 58: 2724-2726
33. Zigman AF et al. (1997) Localization of the Bannayan-Riley-Ruvalcaba syndrome gene to chromosome 10q23. Gastroenterology 113: 1433-1437
34. Zhou XP et al. (2003) Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet 73: 404-411
35. Suzuki A et al. (1998) High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 8: 1169-1178
36. Waite KA and Eng C (2002) Protean PTEN: Form and function. Am J Hum Genet 70: 829-844
37. Chow LM and Baker SJ (2006) PTEN function in normal and neoplastic growth. Cancer Lett 241: 184-196
38. Di Cristofano A et al. (1998) Pten is essential for embryonic development and tumour suppression. Nat Genet 19: 348-355
39. Toccalino H et al. (1973) Juvenile polyps of the rectum and colon. Acta Paediatr Scand 62: 337-340
40. Doxey BW et al. (2005) Inherited polyposis syndromes: Molecular mechanisms, clinicopathology, and genetic testing. Clin Gastroenterol Hepatol 3: 633-641
41. Jass JR et al. (1988) Juvenile polyposis - a precancerous condition. Histopathology 13: 619-630
42. Giardiello FM et al. (1991) Colorectal neoplasia in juvenile polyposis or juvenile polyps. Arch Dis Child 66: 971-975
43. Howe JR et al. (1998) The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol 5: 751-756
44. Sayed MG et al. (2002) Germline SMAD4 or BMPR1A mutations and phenotype of juvenile polyposis. Ann Surg Oncol 9: 901-906
45. Friedl W et al. (2002) Juvenile polyposis: Massive gastric polyposis is more common in MADH4 mutation carriers than in BMPR1A mutation carriers. Hum Genet 111: 108-111
46. Coburn MC et al. (1995) Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol 2: 386-391
47. Schreibman IR et al. (2005) The hamartomatous polyposis syndromes: a clinical and molecular review. Am J Gastroenterol 100: 476-490
48. Brosens LA et al. (2007) Risk of colorectal cancer in juvenile polyposis. Gut 56: 965-967
49. Cao X et al. (2006) Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23 by genomewide high-density single nucleotide polymorphism (SNP) scan and identification of BMPR1A loss of function. J Med Genet 43: E13
50. Gallione CJ et al. (2004) A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet 363: 852-859
51. Waite KA and Eng C (2003) From developmental disorder to heritable cancer: It's all in the BMP/TGF-beta family. Nat Rev Genet 4 763-773
52. Wang J et al. (1995) Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 270: 22044-22049
53. Grady WM et al. (1999) Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res 59: 320-324
54. Grady WM and Markowitz SD (2002) Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet 3: 101-128
55. Howe JR et al. (2004) The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations. J Med Genet 41: 484-491
56. Howe J et al. (2007) ENG mutations in MADH4/BMPR1A mutation negative patients with juvenile polyposis. Clin Genet 71: 91-92
57. Delnatte C et al. (2006) Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes. Am J Hum Genet 78: 1066-1074
58. Tsuchiya KD et al. (1998) Deletion 10q23.2-q23.33 in a patient with gastrointestinal juvenile polyposis and other features of a Cowden-like syndrome. Genes Chromosomes Cancer 21: 113-118
59. Jacoby RF et al. (1997) Del(10)(q22.3q24.1) associated with juvenile polyposis. Am J Med Genet 70: 361-364
60. Eng C and Ji H (1998) Molecular classification of the inherited hamartoma polyposis syndromes: Clearing the muddied waters. Am J Hum Genet 62: 1020-1022
61. Eng C (2001) To be or not to BMP. Nat Genet 28: 105-107
62. Takaku K et al. (1999) Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice. Cancer Res 59: 6113-6117
63. Mishina Y et al. (1995) Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 9: 3027-3037
64. Bourdeau A et al. (1999) A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104: 1343-1351
65. Chan OT and Haghighi P (2006) Hamartomatous polyps of the colon: ganglioneuromatous, stromal, and lipomatous. Arch Pathol Lab Med 130: 1561-1566
66. Jacob S et al. (1998) Neurofibromatosis of the colon: An unusual manifestation of von Recklinghausen's diseases - a case report. Indian J Pathol Microbiol 41: 113-116
67. Schwartz RA (1978) Basal-cell-nevus syndrome and gastrointestinal polyposis. N Engl J Med 299: 49
68. Whitelaw SC et al. (1997) Clinical and molecular features of the hereditary mixed polyposis syndrome. Gastroenterology 112: 327-334
69. Jaeger EE et al. (2003) An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome. Am J Hum Genet 72: 1261-1267
70. Fran DN et al. (2006) Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol 59: 490-498
71. Rubio-Viqueira B and Hidalgo M (2006) Targeting mTOR for cancer treatment. Adv Exp Med Biol 587: 309-327
72. Udd L et al. (2004) Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2. Gastroenterology 127: 1030-1037
73. Brazowski E et al. (2005) Characteristics of familial juvenile polyps expressing cyclooxygenase-2. Am J Gastroenterol 100: 130-138
74. Bosman FT (1999) The hamartoma-adenoma-carcinoma sequence. J Pathol 188: 1-2
75. Perzin KH and Bridge MF (1982) Adenomatous and carcinomatous changes in hamartomatous polyps of the small intestine (Peutz-Jeghers syndrome): report of a case and review of the literature. Cancer 49: 971-983
76. Mills SE and Fechner RE (1982) Unusual adenomatous polyps in juvenile polyposis coli. Am J Surg Pathol 6: 177-183
77. Jansen M et al. (2006) Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis. Gut 55: 1-5
78. Clevers H (2005) Stem cells, asymmetric division and cancer. Nat Genet 37: 1027-1028
79. Bronner M (2003) Gastrointestinal inherited polyposis syndromes. Mod Path 16: 359-365